By Stuart Smith on July 4, 2012
This week, the US Justice Department fined a well-known multinational $3bn (£2bn) for serial corporate malpractice. And –in the manner of a suspended criminal sentence – imposed on company managers up to its chief executive stringent measures for slashing their pay and bonuses should further illegal activity come to light. Another bank getting the Barclays [...]
Posted in Clients, Finance, News, Politics, Research | Tagged $3bn fine, barclays, Bob Diamond, corruption, drugs market, glaxosmithklein, gsk, Jean-Pierre Garnier, medical market, sir andrew Whitty, us legislators
Recent Comments